Crowdai, 236 Clara St, San Francisco, CA 94107, US

Bodyport Inc is a biomarker-guided digital therapeutics company based in San Francisco, CA. They have recently secured FDA 510(k) clearance for their Bodyport Cardiac Scale, a simple and easy-to-use device that integrates a noninvasive biomarker platform to provide comprehensive health insights for heart disease management. With a focus on patient-centered care, Bodyport aims to transform the way heart disease is managed by enabling better prediction, understanding, and intervention in worsening health to prevent hospitalizations and improve quality of life. By combining a user-friendly portal, personalized patient experience, and a robust clinical dashboard, Bodyport's fully integrated solution empowers patients to track their health, stay on treatment, and take action. The novel biomarker platform detects hemodynamic signals through the feet in less than 30 seconds, making daily monitoring as simple as stepping on a familiar at-home scale. With timely alerts and insights, clinical care teams can triage support and take timely action, ultimately improving patient engagement and outcomes.Generated from the website

McQueen LLC

Wolf & Bear Workshop

Pacific West Securities

iCo Therapeutics